Biopharmaceutical Third-Party Logistics Market Analysis

Service (Transportation, Warehousing, and Storage)

Warehousing and storage segment is set to capture around 43.2% biopharmaceutical third-party logistics market share by the end of 2037, primarily driven by increasing demand for biologics and biosimilars and the need for advanced storage solutions, ensuring the integrity and efficacy of temperature-sensitive biologics. The warehousing and storage segment is expected to continue dominating this sector, as logistics companies are investing heavily in expanding their capacity to accommodate the new patterns and trends being followed by ensuring its safe and efficient storage and distribution.

Supply (Cold Chain, Non-cold Chain)

The non-cold chain segment is anticipated to register robust growth during the forecast period owing to the growing demand for ambient and room temperature-stable biologics such as tablets, capsules, or powders. Higher concern towards supply chain flexibility and agility will further push the demand for non-cold chain solutions, as it provides better flexibility in dynamic market conditions. Innovations in the process of packaging and shipping technologies are assisting in transporting non-cold chain biopharmaceuticals more safely and efficiently.

Our in-depth analysis of the market includes the following segments